Vertex Pharmaceuticals Incorporated (VRTX), operates as Biotechnology company in the United States, Europe & internationally. It offers transformative medicines for people with serious diseases of different age groups. It comes under Healthcare – Biotech sector & trades as “VRTX” ticker at Nasdaq.
In weekly, VRTX confirmed higher high above November-2024 high expected in last article. It should continue rally towards 556.9 – 591 area in shorter cycle within May-2026 sequence. We like to buy the pullback in 3, 7 or 11 swings at extreme area, when reach.
VRTX - Elliott Wave Latest Weekly View:
In weekly, it placed ((I)) at $306.08 high (July-2020) & ((II)) at $176.36 low (October-2021). Above there, it ended (I) of ((III)) at $519.88 high (November-2024) & (II) at $362.50 low (August-2025). Within (I), it ended I at $292.75 high, II at $233.01 low, III at $510.63 high, IV at $447.70 low & V at $519.88 high. Within extended III, it placed ((1)) at $324.75 high, ((2)) at $282.21 low, ((3)) at $448.40 high, ((4)) at $391.01 low & ((5)) at $510.63 high. It ended (II) in double three correction. It ended w at $377.85 low in December-2024, x at $519.68 high in March-2025 & y at $362.50 low in August-2025.
VRTX - Elliott Wave View From 3.23.2026:
Above $362.50 low, it ended ((1)) at $507.92 high, ((2)) at $412.27 low & favors rally in ((3)) towards $556.87- $646.41 area. It ended (1) of ((1)) at $403.58 high, (2) at $374.17 low, (3) at $487.52 high, (4) at $450.67 low & (5) at $507.92 high. As expected, it ended ((2)) in price channel against August-2025 before rally continue. Within ((3)), it ended (1) at $456.68 high, (2) at $420.01 low & favors rally in (3). It expects five swings to unfold above $556.87 to finish ((3)). The rally can either in ((3)) as conservative view or can be (1) of ((3)) in more bullish case, if extends more. We like to buy the pullback in 3, 7 or 11 swings at extreme area, when reach.
면책 조항: 본 게시글에 표현된 견해는 전적으로 작성자의 견해이며 Followme의 공식 입장을 대변하지 않습니다. Followme는 제공된 정보의 정확성, 완전성 또는 신뢰성에 대해 책임을 지지 않으며, 서면으로 명시적으로 언급되지 않는 한 해당 내용을 기반으로 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다.


